[ 1 ] López-Gómez JM, Portolés JM, Aljama P. Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality[J]. Kidney Int Suppl, 2008, 111: 75-81.
[ 3 ] Locatelli F, Canaud B, Eckardt KU, et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome[J]. Nephrol Dial Transplant , 2003, 18(7): 1272-1280.
[6]
[ 4 ] Jeong KH, Lee TW, Ihm CG, et al. Polymorphisms in two genes, IL-1B and ACE, are associated with erythropoietin resistance in Korean patients on maintenance hemodialysis[J]. Exp Mol Med, 2008, 40(2): 161-166.
[7]
[ 5 ] Kalantar-Zadeh K, Lee GH, Miller JE, et al. Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients[J]. Am J Kidney Dis, 2009, 53(5): 823-834.